1. Academic Validation
  2. Synthesis of L-2,3-diaminopropionic acid, a siderophore and antibiotic precursor

Synthesis of L-2,3-diaminopropionic acid, a siderophore and antibiotic precursor

  • Chem Biol. 2014 Mar 20;21(3):379-88. doi: 10.1016/j.chembiol.2013.12.011.
Marek J Kobylarz 1 Jason C Grigg 1 Shin-ichi J Takayama 1 Dushyant K Rai 1 David E Heinrichs 2 Michael E P Murphy 3
Affiliations

Affiliations

  • 1 Department of Microbiology and Immunology, Life Sciences Institute, The University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • 2 Department of Microbiology and Immunology, The Centre for Human Immunology, University of Western Ontario, London, ON N6A 5C1, Canada.
  • 3 Department of Microbiology and Immunology, Life Sciences Institute, The University of British Columbia, Vancouver, BC V6T 1Z3, Canada. Electronic address: michael.murphy@ubc.ca.
Abstract

L-2,3-diaminopropionic acid (L-Dap) is an amino acid that is a precursor of Antibiotics and staphyloferrin B a siderophore produced by Staphylococcus aureus. SbnA and SbnB are encoded by the staphyloferrin B biosynthetic gene cluster and are implicated in L-Dap biosynthesis. We demonstrate here that SbnA uses PLP and substrates O-phospho-L-serine and L-glutamate to produce a metabolite N-(1-amino-1-carboxyl-2-ethyl)-glutamic acid (ACEGA). SbnB is shown to use NAD(+) to oxidatively hydrolyze ACEGA to yield α-ketoglutarate and L-Dap. Also, we describe crystal structures of SbnB in complex with NADH and ACEGA as well as with NAD(+) and α-ketoglutarate to reveal the residues required for substrate binding, oxidation, and hydrolysis. SbnA and SbnB contribute to the iron sparing response of S. aureus that enables staphyloferrin B biosynthesis in the absence of an active tricarboxylic acid cycle.

Figures
Products